Toronto, ON — August 29, 2026
Curait Medical patented AI technology was presented during the prestigious Quick Pitch Oral Scientific Session at the 2026 Annual Meeting of the American Society for Radiation Oncology (ASTRO) from September 26–30 in Boston, MA. The abstract, titled Interpretable Artificial Intelligence Decision Support Framework for Online Adaptive Radiotherapy Quality Assurance, was chosen from more than 2,700 peer‑reviewed submissions, placing Curait Medical’s work in the top 10% of all abstracts accepted for oral presentation.
This recognition underscores the accelerating clinical and scientific momentum behind Curait Medical’s Complai™ platform, an AI‑powered quality and decision‑support system designed to modernize and streamline radiation treatment workflows. Complai™ integrates interpretable artificial intelligence, real‑time quality automation, and adaptive radiotherapy decision support—addressing one of the most significant bottlenecks in modern cancer care: the labour‑intensive, time‑critical quality burden in online adaptive radiotherapy.
Scientific Presentation Details
Session
Quick Pitch Oral Scientific Session (QP 11)
Topic
Adaptive Radiation Therapy
Presenter
Jeff Winter
Date/Time
September 28, 2026, 3:00 PM–4:00 PM
Publication
All accepted oral abstracts will appear in the Red Journal supplement and online at redjournal.org.
A Major Milestone for AI‑Enabled Radiation Therapy Quality Processes
The selected abstract (ASTRO #76373) presented by Jeff Winter, demonstrates how Curait Medical’s Complai™ platform enables clinicians to perform rapid, reliable, and transparent quality processes during online adaptive radiotherapy sessions. The work highlights:
• Interpretable AI models that provide clear, clinician‑understandable rationale for each decision
• Automated quality checks that reduce manual workload and variability
• Real‑time decision support that enhances treatment precision and consistency
• Workflow acceleration that improves patient throughput and reduces delays
• A scalable framework designed for broad deployment across radiation oncology departments
This innovation directly supports Curait Medical’s mission to reset radiation treatment quality processes by improving efficiency, consistency, and clinical confidence—ultimately enabling better treatments and better outcomes.
Executive Commentary
“Being selected for a Quick Pitch Oral at ASTRO—one of the most competitive scientific forums in radiation oncology—is a powerful validation of our approach,” said a Curait Medical spokesperson. “Complai™ is built to solve the quality process bottleneck that has limited the scalability of adaptive radiotherapy. This recognition reinforces the clinical relevance and urgency of what we’re delivering.”
About Curait Medical
Curait Medical is a Toronto‑based medical technology company focused on transforming radiation treatment quality through advanced AI, automation, and clinically interpretable decision support. The company’s Complai™ platform is designed to reduce labour burden, improve treatment quality, and enhance patient access to modern adaptive radiotherapy.